SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012053
Filing Date
2020-10-29
Accepted
2020-10-29 16:38:01
Documents
78
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20200930x10q.htm   iXBRL 10-Q 1766129
2 EX-10.3 idra-20200930xex10d3.htm EX-10.3 49569
3 EX-31.1 idra-20200930xex31d1.htm EX-31.1 14215
4 EX-31.2 idra-20200930xex31d2.htm EX-31.2 13925
5 EX-32.1 idra-20200930xex32d1.htm EX-32.1 7148
6 EX-32.2 idra-20200930xex32d2.htm EX-32.2 7757
7 GRAPHIC idra-20200930x10q004.jpg GRAPHIC 4421
8 GRAPHIC idra-20200930x10q011.jpg GRAPHIC 2260
9 GRAPHIC idra-20200930x10q012.jpg GRAPHIC 2312
10 GRAPHIC idra-20200930x10q013.jpg GRAPHIC 2434
11 GRAPHIC idra-20200930x10q014.jpg GRAPHIC 2122
  Complete submission text file 0001558370-20-012053.txt   7461378

Data Files

Seq Description Document Type Size
12 EX-101.SCH idra-20200930.xsd EX-101.SCH 50538
13 EX-101.CAL idra-20200930_cal.xml EX-101.CAL 42725
14 EX-101.DEF idra-20200930_def.xml EX-101.DEF 214127
15 EX-101.LAB idra-20200930_lab.xml EX-101.LAB 410925
16 EX-101.PRE idra-20200930_pre.xml EX-101.PRE 372764
17 EXTRACTED XBRL INSTANCE DOCUMENT idra-20200930x10q_htm.xml XML 1387251
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 201273121
SIC: 2836 Biological Products, (No Diagnostic Substances)